Background illustration for clinical trials search

Paid Clinical Trials Florida

Discover 3,883 paid clinical trials in Florida. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis

for
Seborrheic Keratosis
Location: Coral Gables FL, New Brighton MN, Portland OR
Sponsor: DermBiont, Inc.

Sex: All

Age: 18+

Code: NCT06108024

Phase 2, Recruiting

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Boston MA, Quebec, Fairfield CT, Lake Success NY,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT06290141

Phase 3, Recruiting

The Pre-symptomatic Familial Amyotrophic Lateral Sclerosis (Pre-fALS) Study

for
Amyotrophic Lateral Sclerosis
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT00317616

Recruiting

Innovations in Genicular Outcomes Registry

for
Knee Osteoarthritis
Location: North Chelmsford MA, Garden City NY, Baltimore MD,
Sponsor: Pacira Pharmaceuticals, Inc

Sex: All

Age: 0+

Code: NCT05495334

Recruiting

Comprehensive HIV and Harm Prevention Via Telehealth

for
HIV Infections
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT05897099

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT06144606

Phase 2, Recruiting

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

for
Chronic Lymphocytic Leukemia
Location: Cranston RI, Mount Kisco NY, Elizabeth NJ,
Sponsor: East Valley Hematology and Oncology Medical Group

Sex: All

Age: 18+

Code: NCT00131313

Recruiting

A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder

for
Major Depressive Disorder
Location: Staten Island NY, Orlando FL, Jacksonville FL,
Sponsor: Neuralstem Inc.

Sex: All

Age: 18 - 61

Code: NCT02724735

Recruiting

A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms

for
Benign Prostatic Hyperplasia
Location: Syosset NY, New York NY, Raleigh NC, Daytona Beach FL,
Sponsor: Rivermark Medical

Sex: Male

Age: 45+

Code: NCT06849258

Recruiting

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

for
Pruritus
Location: New York NY, Verdun, Baltimore MD, Washington D.C. DC,
Sponsor: Sanofi

Sex: All

Age: 18 - 70+

Code: NCT05263206

Phase 3, Recruiting

Trial of pasireotideLAR and Topotecan in Relapsed or Refractory Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Miami FL
Sponsor: South Florida Veterans Affairs Foundation for Research and Education

Sex: All

Age: 18+

Code: NCT01417806

Phase 2, Recruiting

Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy

for
Chronic Graft Versus Host Disease
Location: Valhalla NY, Baltimore MD, Miami FL
Sponsor: Kadmon, a Sanofi Company

Sex: All

Age: 12+

Code: NCT05567406

Phase 2, Recruiting

A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma

for
Plasma Cell Myeloma Refractory
Location: Sherbrooke, Hackensack NJ, Montreal, Philadelphia PA,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT06630806

Phase 1, Recruiting

Randomized Placebo-controlled Analysis of Superior Laryngeal Nerve Block for Neurogenic Cough

for
Cough, Nerve Block
Location: Tampa FL
Sponsor: University of South Florida

Sex: All

Age: 18+

Code: NCT04468542

Phase 3, Recruiting

Bifidobacterium Lactis HN019 Supplementation for Prevention of Influenza Infection in Healthy Adults

for
Influenza
Location: Coral Gables FL, Rochester MI
Sponsor: Fonterra Research Centre

Sex: All

Age: 18 - 60

Code: NCT01258842

Phase 3, Recruiting

Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma

for
CNS Lymphoma
Location: Miami FL
Sponsor: Juan P. Alderuccio, MD

Sex: All

Age: 18+

Code: NCT06730542

Phase 1, Recruiting

Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab

for
Atopic Dermatitis
Location: Quincy MA, Johnston RI, Ottawa, Boca Raton FL,
Sponsor: ASLAN Pharmaceuticals

Sex: All

Age: 18+

Code: NCT05694884

Phase 2, Recruiting

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Hagerstown MD, Wildwood FL, The Woodlands TX,
Sponsor: ADARx Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT06990269

Phase 2, Recruiting

A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

for
Focal Segmental Glomerulosclerosis,
Location: Quebec, The Bronx NY, New York NY, Montreal,
Sponsor: Sanofi

Sex: All

Age: 16 - 70+

Code: NCT06500702

Phase 2, Recruiting

Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS

for
Interstitial Cystitis, Bladder Pain Syndrome
Location: Watertown MA, Lake Success NY, Hialeah FL,
Sponsor: Vaneltix Pharma, Inc.

Sex: All

Age: 18+

Code: NCT05737121

Phase 2, Recruiting

Popular cities in Florida

Florida is one of the country’s top states for life sciences and clinical research thanks to its diverse healthcare infrastructure, top talent, and renowned medical research institutions. Major institutions like the University of Florida Health, the Sylvester Comprehensive Cancer Center, and Mayo Clinic Florida are at the forefront of cutting-edge research and clinical studies.

Florida's broad demographic diversity enhances the validity of clinical research, offering a wide range of participants that contribute to more comprehensive study results. This makes Florida a top location for clinical trials, ensuring advancements in treatments are both innovative and highly relevant.

Why choose Florida for clinical trials?

Florida presents unique advantages for those participating in clinical trials. The state's diverse and growing population ensures a wide variety of participants, enhancing the accuracy and relevance of research outcomes. Florida is also recognized for its cutting-edge medical research institutions, with a strong focus on innovative healthcare advancements and groundbreaking clinical studies.

By participating in a clinical trial in Florida, individuals contribute to vital medical research while benefiting from a well-established and supportive clinical research system, making the state an ideal location for advancing medical knowledge and improving healthcare.

Common conditions studied in Florida

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Florida